| Year |
Citation |
Score |
| 2015 |
Opal S, Ellis JL, Suri V, Freudenberg JM, Vlasuk GP, Li Y, Chahin AB, Palardy JE, Parejo N, Yamamoto M, Chahin A, Kessimian N. Sirt1 Activation Markedly Alters Transcription Profiles and Improves Outcome in Experimental Sepsis. Shock (Augusta, Ga.). PMID 26641650 DOI: 10.1097/SHK.0000000000000528 |
0.645 |
|
| 2015 |
Chahin A, Opal SM, Zorzopulos J, Jobes DV, Migdady Y, Yamamoto M, Parejo N, Palardy JE, Horn DL. The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis. Antimicrobial Agents and Chemotherapy. 59: 1225-9. PMID 25512413 DOI: 10.1128/AAC.03923-14 |
0.646 |
|
| 2015 |
Ramachandran G, Kaempfer R, Chung CS, Shirvan A, Chahin AB, Palardy JE, Parejo NA, Chen Y, Whitford M, Arad G, Hillman D, Shemesh R, Blackwelder W, Ayala A, Cross AS, et al. CD28 homodimer interface mimetic peptide acts as a preventive and therapeutic agent in models of severe bacterial sepsis and gram-negative bacterial peritonitis. The Journal of Infectious Diseases. 211: 995-1003. PMID 25305323 DOI: 10.1093/infdis/jiu556 |
0.624 |
|
| 2014 |
Palardy JE, Witman JD. Flow, recruitment limitation, and the maintenance of diversity in marine benthic communities. Ecology. 95: 286-97. PMID 24669723 DOI: 10.1890/12-1612.1 |
0.724 |
|
| 2013 |
Grottoli AG, Matthews KA, Palardy JE, McDonough WF. High resolution coral Cd measurements using LA-ICP-MS and ID-ICP-MS: Calibration and interpretation Chemical Geology. 356: 151-159. DOI: 10.1016/J.Chemgeo.2013.08.024 |
0.599 |
|
| 2011 |
Christaki E, Opal SM, Keith JC, Kessimian N, Palardy JE, Parejo NA, Tan XY, Piche-Nicholas N, Tchistiakova L, Vlasuk GP, Shields KM, Feldman JL, Lavallie ER, Arai M, Mounts W, et al. A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia. Shock (Augusta, Ga.). 35: 492-8. PMID 21263385 DOI: 10.1097/SHK.0b013e31820b2e1c |
0.638 |
|
| 2011 |
Palardy JE, Witman JD. Water flow drives biodiversity by mediating rarity in marine benthic communities. Ecology Letters. 14: 63-8. PMID 21078033 DOI: 10.1111/J.1461-0248.2010.01555.X |
0.722 |
|
| 2011 |
Opal SM, Lim YP, Cristofaro P, Artenstein AW, Kessimian N, Delsesto D, Parejo N, Palardy JE, Siryaporn E. Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection. Shock (Augusta, Ga.). 35: 42-4. PMID 20523269 DOI: 10.1097/SHK.0b013e3181e83204 |
0.609 |
|
| 2010 |
Christaki E, Opal SM, Keith JC, Kessinian N, Palardy JE, Parejo NA, Lavallie E, Racie L, Mounts W, Malamas MS, Mewshaw RE, Harris HA, Vlasuk GP. Estrogen receptor beta agonism increases survival in experimentally induced sepsis and ameliorates the genomic sepsis signature: a pharmacogenomic study. The Journal of Infectious Diseases. 201: 1250-7. PMID 20205571 DOI: 10.1086/651276 |
0.599 |
|
| 2010 |
Gregory SH, Chen WH, Mott S, Palardy JE, Parejo NA, Heninger S, Anderson CA, Artenstein AW, Opal SM, Cross AS. Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4. Vaccine. 28: 2908-15. PMID 20170768 DOI: 10.1016/j.vaccine.2010.01.067 |
0.598 |
|
| 2008 |
Palardy JE, Rodrigues LJ, Grottoli AG. The importance of zooplankton to the daily metabolic carbon requirements of healthy and bleached corals at two depths Journal of Experimental Marine Biology and Ecology. 367: 180-188. DOI: 10.1016/J.Jembe.2008.09.015 |
0.623 |
|
| 2008 |
Matthews KA, Grottoli AG, McDonough WF, Palardy JE. Upwelling, species, and depth effects on coral skeletal cadmium-to-calcium ratios (Cd/Ca) Geochimica Et Cosmochimica Acta. 72: 4537-4550. DOI: 10.1016/J.Gca.2008.05.064 |
0.608 |
|
| 2007 |
Lutterloh EC, Opal SM, Pittman DD, Keith JC, Tan XY, Clancy BM, Palmer H, Milarski K, Sun Y, Palardy JE, Parejo NA, Kessimian N. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Critical Care (London, England). 11: R122. PMID 18042296 DOI: 10.1186/cc6184 |
0.603 |
|
| 2007 |
Opal SM, Lim YP, Siryaporn E, Moldawer LL, Pribble JP, Palardy JE, Souza S. Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis. Critical Care Medicine. 35: 387-92. PMID 17205024 DOI: 10.1097/01.CCM.0000253810.08230.83 |
0.587 |
|
| 2006 |
Cristofaro PA, Opal SM, Palardy JE, Parejo NA, Jhung J, Keith JC, Harris HA. WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock. Critical Care Medicine. 34: 2188-93. PMID 16755255 DOI: 10.1097/01.CCM.0000227173.13497.56 |
0.591 |
|
| 2006 |
Grottoli AG, Rodrigues LJ, Palardy JE. Heterotrophic plasticity and resilience in bleached corals. Nature. 440: 1186-9. PMID 16641995 DOI: 10.1038/Nature04565 |
0.629 |
|
| 2006 |
Palardy JE, Grottoli AG, Matthews KA. Effect of naturally changing zooplankton concentrations on feeding rates of two coral species in the Eastern Pacific Journal of Experimental Marine Biology and Ecology. 331: 99-107. DOI: 10.1016/J.Jembe.2005.10.001 |
0.619 |
|
| 2005 |
Opal SM, Palardy JE, Cristofaro P, Parejo N, Jhung JW, Keith JC, Chippari S, Caggiano TJ, Steffan RJ, Chadwick CC, Harnish DC. The activity of pathway-selective estrogen receptor ligands in experimental septic shock. Shock (Augusta, Ga.). 24: 535-40. PMID 16317384 DOI: 10.1097/01.shk.0000183388.90895.cb |
0.629 |
|
| 2005 |
Opal SM, Palardy JE, Chen WH, Parejo NA, Bhattacharjee AK, Cross AS. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms. The Journal of Infectious Diseases. 192: 2074-80. PMID 16288370 DOI: 10.1086/498167 |
0.617 |
|
| 2005 |
Opal SM, Artenstein AW, Cristofaro PA, Jhung JW, Palardy JE, Parejo NA, Lim YP. Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication. Infection and Immunity. 73: 5101-5. PMID 16041026 DOI: 10.1128/IAI.73.8.5101-5105.2005 |
0.644 |
|
| 2005 |
Palardy JE, Grottoli AG, Matthews KA. Effects of upwelling, depth, morphology and polyp size on feeding in three species of Panamanian corals Marine Ecology Progress Series. 300: 79-89. DOI: 10.3354/Meps300079 |
0.604 |
|
| 2005 |
Grottoli AG, Rodrigues LJ, Matthews KA, Palardy JE, Gibb OT. Pre-treatment effects on coral skeletal θ13C and θ18O Chemical Geology. 221: 225-242. DOI: 10.1016/J.Chemgeo.2005.05.004 |
0.612 |
|
| 2004 |
Artenstein AW, Opal SM, Cristofaro P, Palardy JE, Parejo NA, Green MD, Jhung JW. Chloroquine enhances survival in Bacillus anthracis intoxication. The Journal of Infectious Diseases. 190: 1655-60. PMID 15478072 DOI: 10.1086/424853 |
0.629 |
|
| 2003 |
Cross AS, Opal SM, Palardy JE, Drabick JJ, Warren HS, Huber C, Cook P, Bhattacharjee AK. Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects. Vaccine. 21: 4576-87. PMID 14575770 DOI: 10.1016/S0264-410X(03)00483-3 |
0.606 |
|
| 2003 |
Lim YP, Bendelja K, Opal SM, Siryaporn E, Hixson DC, Palardy JE. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. The Journal of Infectious Diseases. 188: 919-26. PMID 12964125 DOI: 10.1086/377642 |
0.608 |
|
| 2003 |
Opal SM, Palardy JE, Parejo N, Jasman RL. Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia. Critical Care Medicine. 31: 929-32. PMID 12627007 DOI: 10.1097/01.CCM.0000054870.25767.EE |
0.603 |
|
| 2003 |
Opal SM, Keith JC, Jhung J, Palardy JE, Parejo N, Marchese E, Maganti V. Orally administered recombinant human interleukin-11 is protective in experimental neutropenic sepsis. The Journal of Infectious Diseases. 187: 70-6. PMID 12508148 DOI: 10.1086/345864 |
0.608 |
|
| 2001 |
Opal SM, Palardy JE, Parejo N, Morrison DC. Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis. Journal of Endotoxin Research. 7: 35-8. PMID 11521079 DOI: 10.1179/096805101101532503 |
0.653 |
|
| 2001 |
Opal SM, Sypek JP, Keith JC, Schaub RG, Palardy JE, Parejo NA. Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection. Shock (Augusta, Ga.). 15: 285-90. PMID 11303727 |
0.65 |
|
| 2001 |
Cross AS, Opal SM, Warren HS, Palardy JE, Glaser K, Parejo NA, Bhattacharjee AK. Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis. The Journal of Infectious Diseases. 183: 1079-86. PMID 11237833 DOI: 10.1086/319297 |
0.633 |
|
| 2001 |
Opal SM, Palardy JE, Parejo NA, Creasey AA. The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis. Critical Care Medicine. 29: 13-7. PMID 11176151 |
0.595 |
|
| 2000 |
Simpson AJ, Opal SM, Angus BJ, Prins JM, Palardy JE, Parejo NA, Chaowagul W, White NJ. Differential antibiotic-induced endotoxin release in severe melioidosis. The Journal of Infectious Diseases. 181: 1014-9. PMID 10720525 DOI: 10.1086/315306 |
0.635 |
|
| 2000 |
Opal SM, Keith JC, Palardy JE, Parejo N. Recombinant human interleukin-11 has anti-inflammatory actions yet does not exacerbate systemic Listeria infection. The Journal of Infectious Diseases. 181: 754-6. PMID 10669370 DOI: 10.1086/315247 |
0.623 |
|
| 1999 |
Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. The Journal of Infectious Diseases. 180: 1584-9. PMID 10515819 DOI: 10.1086/315093 |
0.6 |
|
| 1999 |
Opal SM, Jhung JW, Keith JC, Goldman SJ, Palardy JE, Parejo NA. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis. Blood. 93: 3467-72. PMID 10233899 |
0.648 |
|
| 1998 |
Opal SM, Jhung JW, Keith JC, Palardy JE, Parejo NA, Young LD, Bhattacharjee A. Recombinant human interleukin-11 in experimental Pseudomonas aeruginosa sepsis in immunocompromised animals. The Journal of Infectious Diseases. 178: 1205-8. PMID 9806062 |
0.657 |
|
| 1996 |
Opal SM, Cross AS, Jhung JW, Young LD, Palardy JE, Parejo NA, Donsky C. Potential hazards of combination immunotherapy in the treatment of experimental septic shock. The Journal of Infectious Diseases. 173: 1415-21. PMID 8648214 |
0.633 |
|
| 1996 |
Opal SM, Horn DL, Palardy JE, Parejo N, Jhung J, Bhattacharjee A, Young LD. The in vivo significance of antibiotic-induced endotoxin release in experimental Gram-negative sepsis Innate Immunity. 3: 245-252. DOI: 10.1177/096805199600300310 |
0.611 |
|
| 1996 |
Opal SM, Horn DL, Palardy JE, Parejo N, Jhung J, Bhattacharjee A, Young LD. The in vivo significance of antibiotic induced endotoxin release in experimental Gram-negative sepsis Journal of Endotoxin Research. 3: 245-252. |
0.611 |
|
| 1995 |
Opal SM, Palardy JE, Jhung JW, Donsky C, Romulo RL, Parejo N, Marra MN. Activity of lipopolysaccharide-binding protein-bactericidal/permeability-increasing protein fusion peptide in an experimental model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy. 39: 2813-5. PMID 8593028 |
0.611 |
|
| 1994 |
Fisher CJ, Marra MN, Palardy JE, Marchbanks CR, Scott RW, Opal SM. Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study. Critical Care Medicine. 22: 553-8. PMID 8143463 |
0.615 |
|
| 1994 |
Suitters AJ, Foulkes R, Opal SM, Palardy JE, Emtage JS, Rolfe M, Stephens S, Morgan A, Holt AR, Chaplin LC. Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock. The Journal of Experimental Medicine. 179: 849-56. PMID 8113678 |
0.632 |
|
| 1994 |
Bhattacharjee AK, Opal SM, Palardy JE, Drabick JJ, Collins H, Taylor R, Cotton A, Cross AS. Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis. The Journal of Infectious Diseases. 170: 622-9. PMID 8077720 DOI: 10.1093/infdis/170.3.622 |
0.629 |
|
| 1994 |
Opal SM, Palardy JE, Marra MN, Fisher CJ, McKelligon BM, Scott RW. Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet (London, England). 344: 429-31. PMID 7520106 DOI: 10.1016/S0140-6736(94)91767-1 |
0.632 |
|
| 1993 |
Romulo RL, Palardy JE, Opal SM. Efficacy of anti-endotoxin monoclonal antibody E5 alone or in combination with ciprofloxacin in neutropenic rats with Pseudomonas sepsis. The Journal of Infectious Diseases. 167: 126-30. PMID 8418159 |
0.635 |
|
| 1993 |
Cross AS, Opal SM, Palardy JE, Bodmer MW, Sadoff JC. The efficacy of combination immunotherapy in experimental Pseudomonas sepsis. The Journal of Infectious Diseases. 167: 112-8. PMID 8418157 DOI: 10.1093/infdis/167.1.112 |
0.65 |
|
| 1991 |
Opal SM, Cross AS, Sadoff JC, Collins HH, Kelly NM, Victor GH, Palardy JE, Bodmer MW. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis. The Journal of Clinical Investigation. 88: 885-90. PMID 1885775 DOI: 10.1172/JCI115390 |
0.653 |
|
| 1990 |
Opal SM, Cross AS, Kelly NM, Sadoff JC, Bodmer MW, Palardy JE, Victor GH. Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa. The Journal of Infectious Diseases. 161: 1148-52. PMID 2140582 DOI: 10.1093/infdis/161.6.1148 |
0.65 |
|
| Show low-probability matches. |